Acepodia (ROCO:6976) FCF Yield % : -2.95 (As of May. 27, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Acepodia FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Acepodia's Trailing 12-Month Free Cash Flow is NT$-462.09 Mil, and Market Cap is NT$15,649.65 Mil. Therefore, Acepodia's FCF Yield % for today is -2.95%.

The historical rank and industry rank for Acepodia's FCF Yield % or its related term are showing as below:

ROCO:6976' s FCF Yield % Range Over the Past 10 Years
Min: -3.07 Med: -2.82 Max: -2.51
Current: -2.95

During the past 4 years, the highest FCF Yield % of Acepodia was -2.51%. The lowest was -3.07%. And the median was -2.82%.

ROCO:6976's FCF Yield % is ranked better than
77.08% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs ROCO:6976: -2.95

Acepodia's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

Acepodia FCF Yield % Historical Data

The historical data trend for Acepodia's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia FCF Yield % Chart

Acepodia Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-2.38

Acepodia Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-	-	-	-	-2.94

Competitive Comparison of Acepodia's FCF Yield %

For the Biotechnology subindustry, Acepodia's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acepodia's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acepodia's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Acepodia's FCF Yield % falls into.

Acepodia FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Acepodia's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-462.087	/	19420.298
	=	-2.38%

Acepodia's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-176.444	*	2	/	0
	=	N/A%

Acepodia FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Acepodia FCF Yield % Related Terms

Thank you for viewing the detailed overview of Acepodia's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Acepodia (ROCO:6976) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175

Website

https://www.acepodia.com

Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia (ROCO:6976) Headlines

No Headlines